Studies have indicated that lung epithelial cell-specific loss of α3 integrin expression reduced EMT and protected from lung fibrosis, apparently by inhibiting tyrosine phosphorylation of β-catenin and formation of β-catenin/Smad2 complex, and it was confirmed in IPF patients [27]. The gene discussed is SMAD2; the disease is pulmonary fibrosis.